미숙아 동맥관 개존증의 예방적 치료로서 Indomethacin과 Ibuprofen의 효과 = Effects of Ibuprofen and Indomethacin for Prophylaxis of Patent Ductus Arteriosus in Premature Infants

다국어 초록 (Multilingual Abstract)

Purpose: The aim of our study was to compare the efficacy and safety of ibuprofen and indomethacin in the prophylaxis of patent ductus arteriosus (PDA) in preterm infants and to determine whether ibuprofen could be an alternative agent in prophylactic use.
Methods: A retrospective study including 37 preterm infants <1,500 g of birth weight, <34 weeks of gestation, whom were administrated indomethacin (n=17; January 2009-December 2009) or ibuprofen (n=20; January 2010-February 2011) within 24 hr after birth was conducted. The rate of ductal closure, need for surgical ligation, clinical outcomes such as necrotizing enterocolitis,intraventricular hemorrhage, bronchopulmonary dysplasia, retinopathy of prematurity (ROP) and death rate were compared.
Results: There were no statistically significant differences between the two groups in mean gestational age, mean birth weight,Apgar score, sex, type of delivery, maternal dexamethasone treatment, frequency and duration of ventilator and surfactant treatment.
The closure of PDA on day 7 of life was in 19 of 20 infants of the ibuprofen group and 13 of 17 infants of the indomethacin group (P=0.159). Between the two groups, there were no significant differences with respect to clinical outcomes.
Conclusion: Ibuprofen has similar effects to indomethacin in the rate of PDA closure. Our study demonstrates that prophylactic ibuprofen is relatively effective without significant differences with respect to clinical outcomes compared with indomethacin.
Therefore, ibuprofen may be used as an alternative agent in the prophylaxis of PDA in preterm infants.

참고문헌 (Reference)

1 이수진, "호흡곤란 증후군 미숙아에서 동맥관 개존증의 약물 치료 : 경구용 ibuprofen과 indomethacin의 비교" 대한소아과학회 51 (51): 956-963, 2008

2 Van Overmeire B, "Treatment of patent ductus arteriosus with ibuprofen" 76 : F179-F184, 1997

3 Wyllie J, "Treatment of patent ductus arteriosus" 8 : 425-432, 2003

4 Coceani F, "The response of the ductus arteriosus to prostaglandins" 51 : 220-225, 1973

5 Seo JY, "The factors associated with oliguria after indomethacin administration in preterm infants with patent ductus arteriosus" 9 : 65-73, 2002

6 Perlman JM, "The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries : ductal steal in the premature newborn infant" 99 : 767-771, 1981

7 Patel J, "Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus" 47 : 36-42, 2000

8 Farstad T, "Pulmonary effects of closure of patent ductus arteriosus in premature infants with severe respiratory distress syndrome" 153 : 903-905, 1994

9 Dani C, "Prophylaxis of patent ductus arteriosus with ibuprofen in preterm Infants" 89 : 1369-1374, 2000

10 Gournay V, "Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial" 364 : 1939-1944, 2004

11 De Carolis MP, "Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants" 159 : 364-368, 2000

12 Friedmann WF, "Pharmacologic closure of patent ductus arteriosus in the premature infant" 295 : 526-529, 1976

13 Hammerman C, "Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment" 22 : 457-479, 1995

14 Van Bel F, "Indomethacin- induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging" 118 : 621-626, 1991

15 Papile LA, "Incidence and evolution of subependymal and intraventricular hemorrhage : a study of infants with birth weights less than 1,500 gm" 92 : 529-534, 1978

16 Patel J, "Ibuprofen treatment of patent ductus arteriosus" 346 : 255-, 1995

17 Shah SS, "Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants" 203 (203): CD004213-,

18 Overturf GD, "Focal bacterial infection. In Infectious disease of the fetus and newborn infants. 5th ed" Philadelphia : WB Saunders Co 1058-1063, 2001

19 Romagnoli C, "Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates" 67 : 676-683, 2000

20 Edwards AD, "Effects of indomethacin on cerebral haemodynamics in very preterm infants" 335 : 1491-1495, 1990

21 Pezzati M, "Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus" 135 : 733-738, 1999

22 Seok EJ, "Effect of indomethacin therapy on prevention of intraventricular hemorrhage in very low birth weight infant" 5 : 27-34, 1998

23 Van Bel F, "Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants" 116 : 965-970, 1990

24 Merritt TA, "Early closure of the patent ductus arteriosus in very lowbirth- weight infants: a controlled trial" 99 : 281-286, 1981

25 Drummond WH, "Ductus arteriosus. In Intensive care of the fetus and neonate. 2nd ed" Louis: CV Mosby Co 760-761, 1996

26 Mosca F, "Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus" 131 : 549-554, 1997

27 Stefano JL, "Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation" 143 : 236-239, 1991

28 Jobe AH, "Bronchopulmonary dysplasia" 163 : 1723-1729, 2001

29 "An international classification of retinopathy of prematurity. II. The classification of retinal detachment" The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity 105 : 906-912, 1987

30 Coceani F, "Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen" 57 : 825-831, 1979

31 Van Overmeire B, "A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus" 343 : 674-681, 2000